Thermo Fisher sees Q1 EPS 22% of full-year total, consensus $4.99

Sees Q1 core organic revenue growth similar to Q4. Sees FY24 adjusted operating margin 22.3%-22.8% Sees FY24 capital expenditures $1.3B-$1.5B. Sees FY24 free cash flow $6.5B-$7B .Says goal is utilizing 80% renewable energy by 2030. Says assuming market declines in low-single digits in FY24. Says M&A is expected to increase revenue by $100M in FY24. Says expects foreign exchange to have neutral impact in FY24. Says expects to close acquisition of Olink by mid year. Comments and guidance taken from Q4 earnings conference call.